Our Advisory Team
Dr. Jonathan Seltzer
MD, MBA, MA, FACC
Dr. Seltzer has received board certification in both cardiology and internal medicine and holds a B.A. from Haverford College, an MBA and M.A. from the University of Michigan and an M.D. from the University of Pennsylvania. Dr. Seltzer received postgraduate medical training at the University of Michigan, University of Maryland and University of Chicago. He is a Fellow of the American College of Cardiology and also currently serves as Director of Clinical Research at the Main Line Health Heart Center.
Dr. Seltzer is advisory role to Agati is specifically focused on Medical & Clinical Consultations.
Max Rashed brings extensive experience in operations, financial and asset management working for top Fortune 500 companies. Mr. Rashed held executive leadership positions in the drug development industry, managing several aspects of clinical research at global levels, interfacing with sponsors, medical centers, labs & governmental drug agencies. Rashed completed an Executive Masters of Business Administration from Michigan State University.
Diego Herrera, B.Sc Life Science graduated at Barcelona Central University, specialized in Laboratory of Hematology and Biochemistry Analysis and titled professor of Laboratory Technician School in Barcelona.
He currently occupies the position of Head in Clinical Data and Information Management in Almirall SA (Spain). His almost 30 years professional evolution has been developed in different Clinical Development functions, from site monitoring, clinical project management, Clinical IT manager, leading clinical technology projects for process transformation in clinical development. He is author of numerous oral publications and an expert in innovation in clinical trials.
Klaus-Dieter Albrecht is an experienced and versatile clinical development and business professional with 30 years of global clinical research expertise, in combination with a pharmacy registration (approbierter Apotheker). He gained extensive clinical research leadership expertise in various positions, including seven year’s experience as the founder, owner and CEO of a global Contract Research Organization. Since 2012 he is focusing on the Medical Device Industry. He acquired a deep understanding of the current regulations (e.g. Meddev 2.7/1 rev. 4 and MDR 2017/745) and the impact on the industry.